Nanogen's advanced technologies provided researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately, help treat disease. The company's products included real-time PCR reagents, the NanoChip(R) 400 electronic microarray platform and a line of rapid, point-of-care diagnostic tests. Nanogen was acquired by Epoch Biosciences in 2009.